Skip to main content
Top
Published in: Discover Oncology 6/2011

01-12-2011

Steroid Profiling by Gas Chromatography–Mass Spectrometry and High Performance Liquid Chromatography–Mass Spectrometry for Adrenal Diseases

Authors: Jeffrey G. McDonald, Susan Matthew, Richard J. Auchus

Published in: Discover Oncology | Issue 6/2011

Login to get access

Abstract

The ability to measure steroid hormone concentrations in blood and urine specimens is central to the diagnosis and proper treatment of adrenal diseases. The traditional approach has been to assay each steroid hormone, precursor, or metabolite using individual aliquots of serum, each with a separate immunoassay. For complex diseases, such as congenital adrenal hyperplasia and adrenocortical cancer, in which the assay of several steroids is essential for management, this approach is time consuming and costly, in addition to using large amounts of serum. Gas chromatography/mass spectrometry profiling of steroid metabolites in urine has been employed for many years but only in a small number of specialized laboratories and suffers from slow throughput. The advent of commercial high-performance liquid chromatography instruments coupled to tandem mass spectrometers offers the potential for medium- to high-throughput profiling of serum steroids using small quantities of sample. Here, we review the physical principles of mass spectrometry, the instrumentation used for these techniques, the terminology used in this field and applications to steroid analysis.
Literature
1.
go back to reference Abraham GE (1969) Solid-phase radioimmunoassay of estradiol-17β. J Clin Endocrinol Metab 29:866–870PubMedCrossRef Abraham GE (1969) Solid-phase radioimmunoassay of estradiol-17β. J Clin Endocrinol Metab 29:866–870PubMedCrossRef
2.
go back to reference Shackleton CHL (1985) Mass spectrometry: application to steroid and peptide research. Endocr Rev 6:441–486PubMedCrossRef Shackleton CHL (1985) Mass spectrometry: application to steroid and peptide research. Endocr Rev 6:441–486PubMedCrossRef
3.
go back to reference Zhang Y, Tobias HJ, Brenna JT (2009) Steroid isotopic standards for gas chromatography–combustion isotope ratio mass spectrometry (GCC-IRMS). Steroids 74:369–378PubMedCrossRef Zhang Y, Tobias HJ, Brenna JT (2009) Steroid isotopic standards for gas chromatography–combustion isotope ratio mass spectrometry (GCC-IRMS). Steroids 74:369–378PubMedCrossRef
4.
go back to reference Penning TM, Lee SH, Jin Y, Gutierrez A, Blair IA (2010) Liquid chromatography-mass spectrometry (LC-MS) of steroid hormone metabolites and its applications. J Steroid Biochem Mol Biol 121:546–555PubMedCrossRef Penning TM, Lee SH, Jin Y, Gutierrez A, Blair IA (2010) Liquid chromatography-mass spectrometry (LC-MS) of steroid hormone metabolites and its applications. J Steroid Biochem Mol Biol 121:546–555PubMedCrossRef
5.
go back to reference Yamashita K, Miyashiro Y, Maekubo H, Okuyama M, Honma S, Takahashi M, Numazawa M (2009) Development of highly sensitive quantification method for testosterone and dihydrotestosterone in human serum and prostate tissue by liquid chromatography-electrospray ionization tandem mass spectrometry. Steroids 74:920–926PubMedCrossRef Yamashita K, Miyashiro Y, Maekubo H, Okuyama M, Honma S, Takahashi M, Numazawa M (2009) Development of highly sensitive quantification method for testosterone and dihydrotestosterone in human serum and prostate tissue by liquid chromatography-electrospray ionization tandem mass spectrometry. Steroids 74:920–926PubMedCrossRef
6.
go back to reference Shackleton CH (1993) Mass spectrometry in the diagnosis of steroid-related disorders and in hypertension research. J Steroid Biochem Mol Biol 45:127–140PubMedCrossRef Shackleton CH (1993) Mass spectrometry in the diagnosis of steroid-related disorders and in hypertension research. J Steroid Biochem Mol Biol 45:127–140PubMedCrossRef
7.
go back to reference Krone N, Hughes BA, Lavery GG, Stewart PM, Arlt W, Shackleton CH (2010) Gas chromatography/mass spectrometry (GC/MS) remains a pre-eminent discovery tool in clinical steroid investigations even in the era of fast liquid chromatography tandem mass spectrometry (LC/MS/MS). J Steroid Biochem Mol Biol 121:496–504PubMedCrossRef Krone N, Hughes BA, Lavery GG, Stewart PM, Arlt W, Shackleton CH (2010) Gas chromatography/mass spectrometry (GC/MS) remains a pre-eminent discovery tool in clinical steroid investigations even in the era of fast liquid chromatography tandem mass spectrometry (LC/MS/MS). J Steroid Biochem Mol Biol 121:496–504PubMedCrossRef
8.
go back to reference Therrell BLJ, Berenbaum SA, Manter-Kapanke V, Simmank J, Korman K, Prentice L, Gonzalez J, Gunn S (1998) Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia. Pediatrics 101:583–590PubMedCrossRef Therrell BLJ, Berenbaum SA, Manter-Kapanke V, Simmank J, Korman K, Prentice L, Gonzalez J, Gunn S (1998) Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia. Pediatrics 101:583–590PubMedCrossRef
9.
go back to reference Caulfield MP, Lynn T, Gottschalk ME, Jones KL, Taylor NF, Malunowicz EM, Shackleton CH, Reitz RE, Fisher DA (2002) The diagnosis of congenital adrenal hyperplasia in the newborn by gas chromatography/mass spectrometry analysis of random urine specimens. J Clin Endocrinol Metab 87:3682–3690PubMedCrossRef Caulfield MP, Lynn T, Gottschalk ME, Jones KL, Taylor NF, Malunowicz EM, Shackleton CH, Reitz RE, Fisher DA (2002) The diagnosis of congenital adrenal hyperplasia in the newborn by gas chromatography/mass spectrometry analysis of random urine specimens. J Clin Endocrinol Metab 87:3682–3690PubMedCrossRef
10.
go back to reference Wudy SA, Hartmann M, Homoki J (2000) Hormonal diagnosis of 21-hydroxylase deficiency in plasma and urine of neonates using benchtop gas chromatography–mass spectrometry. J Endocrinol 165:679–683PubMedCrossRef Wudy SA, Hartmann M, Homoki J (2000) Hormonal diagnosis of 21-hydroxylase deficiency in plasma and urine of neonates using benchtop gas chromatography–mass spectrometry. J Endocrinol 165:679–683PubMedCrossRef
11.
go back to reference Homma K, Hasegawa T, Takeshita E, Watanabe K, Anzo M, Toyoura T, Jinno K, Ohashi T, Hamajima T, Takahashi Y, Takahashi T, Matsuo N (2004) Elevated urine pregnanetriolone definitively establishes the diagnosis of classical 21-hydroxylase deficiency in term and preterm neonates. J Clin Endocrinol Metab 89:6087–6091PubMedCrossRef Homma K, Hasegawa T, Takeshita E, Watanabe K, Anzo M, Toyoura T, Jinno K, Ohashi T, Hamajima T, Takahashi Y, Takahashi T, Matsuo N (2004) Elevated urine pregnanetriolone definitively establishes the diagnosis of classical 21-hydroxylase deficiency in term and preterm neonates. J Clin Endocrinol Metab 89:6087–6091PubMedCrossRef
12.
go back to reference Tiu SC, Chan AO, Taylor NF, Lee CY, Loung PY, Choi CH, Shek CC (2009) Use of urinary steroid profiling for diagnosing and monitoring adrenocortical tumours. Hong Kong Med J 15:463–470PubMed Tiu SC, Chan AO, Taylor NF, Lee CY, Loung PY, Choi CH, Shek CC (2009) Use of urinary steroid profiling for diagnosing and monitoring adrenocortical tumours. Hong Kong Med J 15:463–470PubMed
13.
go back to reference Khorram-Manesh A, Ahlman H, Jansson S, Wangberg B, Nilsson O, Jakobsson CE, Eliasson B, Lindstedt S, Tisell LE (1998) Adrenocortical carcinoma: surgery and mitotane for treatment and steroid profiles for follow-up. World J Surg 22:605–611, discussion 611–612PubMedCrossRef Khorram-Manesh A, Ahlman H, Jansson S, Wangberg B, Nilsson O, Jakobsson CE, Eliasson B, Lindstedt S, Tisell LE (1998) Adrenocortical carcinoma: surgery and mitotane for treatment and steroid profiles for follow-up. World J Surg 22:605–611, discussion 611–612PubMedCrossRef
14.
go back to reference Arlt W, Biehl M, Taylor AE, Hahner S, Libe R, Hughes BA, Schneider P, Smith DJ, Stiekema H, Krone N, Porfiri E, Opocher G, Bertherat J, Mantero F, Allolio B, Terzolo M, Nightingale P, Shackleton CH, Bertagna X, Fassnacht M, Stewart PM (2011) Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors. J Clin Endocrinol Metab 96:3775–3784 Arlt W, Biehl M, Taylor AE, Hahner S, Libe R, Hughes BA, Schneider P, Smith DJ, Stiekema H, Krone N, Porfiri E, Opocher G, Bertherat J, Mantero F, Allolio B, Terzolo M, Nightingale P, Shackleton CH, Bertagna X, Fassnacht M, Stewart PM (2011) Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors. J Clin Endocrinol Metab 96:3775–3784
15.
go back to reference Kushnir MM, Rockwood AL, Roberts WL, Yue B, Bergquist J, Meikle AW (2011) Liquid chromatography tandem mass spectrometry for analysis of steroids in clinical laboratories. Clin Biochem 44:77–88PubMedCrossRef Kushnir MM, Rockwood AL, Roberts WL, Yue B, Bergquist J, Meikle AW (2011) Liquid chromatography tandem mass spectrometry for analysis of steroids in clinical laboratories. Clin Biochem 44:77–88PubMedCrossRef
16.
go back to reference Rauh M (2010) Steroid measurement with LC-MS/MS. Application examples in pediatrics. J Steroid Biochem Mol Biol 121:520–527PubMedCrossRef Rauh M (2010) Steroid measurement with LC-MS/MS. Application examples in pediatrics. J Steroid Biochem Mol Biol 121:520–527PubMedCrossRef
17.
go back to reference Janzen N, Peter M, Sander S, Steuerwald U, Terhardt M, Holtkamp U, Sander J (2007) Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry. J Clin Endocrinol Metab 92:2581–2589PubMedCrossRef Janzen N, Peter M, Sander S, Steuerwald U, Terhardt M, Holtkamp U, Sander J (2007) Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry. J Clin Endocrinol Metab 92:2581–2589PubMedCrossRef
18.
go back to reference Minutti CZ, Lacey JM, Magera MJ, Hahn SH, McCann M, Schulze A, Cheillan D, Dorche C, Chace DH, Lymp JF, Zimmerman D, Rinaldo P, Matern D (2004) Steroid profiling by tandem mass spectrometry improves the positive predictive value of newborn screening for congenital adrenal hyperplasia. J Clin Endocrinol Metab 89:3687–3693PubMedCrossRef Minutti CZ, Lacey JM, Magera MJ, Hahn SH, McCann M, Schulze A, Cheillan D, Dorche C, Chace DH, Lymp JF, Zimmerman D, Rinaldo P, Matern D (2004) Steroid profiling by tandem mass spectrometry improves the positive predictive value of newborn screening for congenital adrenal hyperplasia. J Clin Endocrinol Metab 89:3687–3693PubMedCrossRef
19.
go back to reference Guo T, Taylor RL, Singh RJ, Soldin SJ (2006) Simultaneous determination of 12 steroids by isotope dilution liquid chromatography-photospray ionization tandem mass spectrometry. Clin Chim Acta 372:76–82PubMedCrossRef Guo T, Taylor RL, Singh RJ, Soldin SJ (2006) Simultaneous determination of 12 steroids by isotope dilution liquid chromatography-photospray ionization tandem mass spectrometry. Clin Chim Acta 372:76–82PubMedCrossRef
20.
go back to reference Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H (2007) Position statement: utility, limitations, and pitfalls in measuring testosterone: an endocrine society position statement. J Clin Endocrinol Metab 92:405–413PubMedCrossRef Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H (2007) Position statement: utility, limitations, and pitfalls in measuring testosterone: an endocrine society position statement. J Clin Endocrinol Metab 92:405–413PubMedCrossRef
21.
go back to reference Mitchell IC, Auchus RJ, Juneja K, Chang AY, Holt SA, Snyder WH 3rd, Nwariaku FE (2007) “Subclinical Cushing’s syndrome” is not subclinical: improvement after adrenalectomy in 9 patients. Surgery 142:900–905PubMedCrossRef Mitchell IC, Auchus RJ, Juneja K, Chang AY, Holt SA, Snyder WH 3rd, Nwariaku FE (2007) “Subclinical Cushing’s syndrome” is not subclinical: improvement after adrenalectomy in 9 patients. Surgery 142:900–905PubMedCrossRef
Metadata
Title
Steroid Profiling by Gas Chromatography–Mass Spectrometry and High Performance Liquid Chromatography–Mass Spectrometry for Adrenal Diseases
Authors
Jeffrey G. McDonald
Susan Matthew
Richard J. Auchus
Publication date
01-12-2011
Publisher
Springer-Verlag
Published in
Discover Oncology / Issue 6/2011
Print ISSN: 1868-8497
Electronic ISSN: 2730-6011
DOI
https://doi.org/10.1007/s12672-011-0099-x

Other articles of this Issue 6/2011

Discover Oncology 6/2011 Go to the issue